- Home
- TLSA vs ETON Comparison
TLSA vs ETON Comparison
Compare TLSA & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- ETON
- Stock Information
- Founded
- TLSA 2013
- ETON 2017
- Country
- TLSA United Kingdom
- ETON United States
- Employees
- TLSA N/A
- ETON N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- TLSA Health Care
- ETON Health Care
- Exchange
- TLSA Nasdaq
- ETON Nasdaq
- Market Cap
- TLSA 87.8M
- ETON 199.5M
- IPO Year
- TLSA 2000
- ETON 2018
- Fundamental
- Price
- TLSA $1.20
- ETON $8.77
- Analyst Decision
- TLSA
- ETON Strong Buy
- Analyst Count
- TLSA 0
- ETON 3
- Target Price
- TLSA N/A
- ETON $12.00
- AVG Volume (30 Days)
- TLSA 145.8K
- ETON 214.1K
- Earning Date
- TLSA 05-10-2024
- ETON 11-11-2024
- Dividend Yield
- TLSA N/A
- ETON N/A
- EPS Growth
- TLSA N/A
- ETON N/A
- EPS
- TLSA N/A
- ETON N/A
- Revenue
- TLSA N/A
- ETON $31,381,000.00
- Revenue This Year
- TLSA N/A
- ETON $19.61
- Revenue Next Year
- TLSA N/A
- ETON $35.39
- P/E Ratio
- TLSA N/A
- ETON N/A
- Revenue Growth
- TLSA N/A
- ETON 8.14
- 52 Week Low
- TLSA $0.41
- ETON $3.03
- 52 Week High
- TLSA $1.74
- ETON $8.66
- Technical
- Relative Strength Index (RSI)
- TLSA 65.44
- ETON 76.07
- Support Level
- TLSA $0.83
- ETON $7.58
- Resistance Level
- TLSA $0.92
- ETON $8.66
- Average True Range (ATR)
- TLSA 0.09
- ETON 0.42
- MACD
- TLSA 0.03
- ETON -0.07
- Stochastic Oscillator
- TLSA 84.52
- ETON 91.49
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.